|Articles|January 9, 2023

Premier Research and CENTOGENE Launch Strategic Partnership

Collaboration will aim to improve patient identification, stratification, recruitment, and enrollment in rare disease trials.

Premier Research and CENTOGENE have announced a strategic partnership to provide end-to-end support in rare disease clinical trials. The collaboration aims to improve patient identification, stratification, recruitment, and enrollment.

Read more about the new partnership here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content